当前位置:首页 - 行情中心 - 蔚蓝生物(603739) - 财务分析 - 现金流量表

蔚蓝生物

(603739)

  

流通市值:37.25亿  总市值:37.25亿
流通股本:2.53亿   总股本:2.53亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,049,571,792.13707,480,406.78376,443,662.81,291,840,327.68
  收到的税费返还3,639,543.232,336,648.431,665,440.612,496,019.32
  收到其他与经营活动有关的现金35,065,700.0824,440,927.896,416,605.2676,331,639.09
  经营活动现金流入小计1,088,277,035.44734,257,983.1384,525,708.671,370,667,986.09
  购买商品、接受劳务支付的现金611,556,132.43415,825,838.35206,020,731.88626,485,350.58
  支付给职工以及为职工支付的现金178,534,315.16128,626,327.7577,034,647.91228,550,244.45
  支付的各项税费75,018,002.9750,432,510.7926,296,269.3386,334,252.52
  支付其他与经营活动有关的现金189,411,813.07129,247,674.6867,556,952.79233,890,566.77
  经营活动现金流出小计1,054,520,263.63724,132,351.57376,908,601.911,175,260,414.32
  经营活动产生的现金流量净额33,756,771.8110,125,631.537,617,106.76195,407,571.77
二、投资活动产生的现金流量:
  取得投资收益收到的现金1,212,789.88558,896.79-16,360,106.44
  处置固定资产、无形资产和其他长期资产收回的现金净额398,570.39844.372,7142,077,529.86
  处置子公司及其他营业单位收到的现金净额---406,794.34
  收到的其他与投资活动有关的现金677,910,000562,880,000242,600,000932,655,482.91
  投资活动现金流入小计679,521,360.27563,439,741.16242,602,714951,499,913.55
  购建固定资产、无形资产和其他长期资产支付的现金43,685,575.4536,264,988.1841,340,500.86104,719,737.33
  投资支付的现金437,500437,500-24,375,000
  取得子公司及其他营业单位支付的现金---18,360,000
  支付其他与投资活动有关的现金676,911,000520,280,000284,100,495846,503,218.85
  投资活动现金流出小计721,034,075.45556,982,488.18325,440,995.86993,957,956.18
  投资活动产生的现金流量净额-41,512,715.186,457,252.98-82,838,281.86-42,458,042.63
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,580,000780,000780,000-
  其中:子公司吸收少数股东投资收到的现金1,580,000780,000780,000-
  取得借款收到的现金528,973,730.79365,687,913.25139,470,088.29842,678,389.09
  筹资活动现金流入小计530,553,730.79366,467,913.25140,250,088.29842,678,389.09
  偿还债务支付的现金500,087,262.88383,531,423.2660,050,000915,246,820.27
  分配股利、利润或偿付利息支付的现金60,116,375.8254,756,913.8413,567,661.7968,902,487.55
  其中:子公司支付给少数股东的股利、利润22,571,800.0321,100,0009,300,00013,668,532.72
  筹资活动现金流出小计560,203,638.7438,288,337.173,617,661.79984,149,307.82
  筹资活动产生的现金流量净额-29,649,907.91-71,820,423.8566,632,426.5-141,470,918.73
四、汇率变动对现金及现金等价物的影响---126,900.55
五、现金及现金等价物净增加额-37,405,851.28-55,237,539.34-8,588,748.611,605,510.96
  加:期初现金及现金等价物余额233,326,458.32233,326,458.32233,326,458.32221,720,947.36
  期末现金及现金等价物余额195,920,607.04178,088,918.98224,737,709.72233,326,458.32
补充资料:
  净利润-39,804,417.47-92,172,274.48
  资产减值准备--860,799.97-2,684,134.98
  固定资产和投资性房地产折旧-50,304,782.76-101,247,766.7
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-50,304,782.76-101,247,766.7
  无形资产摊销-4,525,179.76-9,738,713.12
  长期待摊费用摊销-558,371.59-1,207,508.1
  处置固定资产、无形资产和其他长期资产的损失--393,279.13-602,390.96
  固定资产报废损失---475,657.22
  公允价值变动损失--4,166,982.33--8,317,637.54
  财务费用-8,582,869.11-21,878,828.93
  投资损失-126,522.53-1,239,485.35
  递延所得税--3,595,388.71--493,706.13
  其中:递延所得税资产减少--4,538,589.18-1,071,641.33
    递延所得税负债增加-943,200.47--1,565,347.46
  存货的减少--34,651,439.93-13,844,769.31
  经营性应收项目的减少--24,674,637.59--40,879,324.66
  经营性应付项目的增加--28,394,707.89--6,460,650.3
  现金的期末余额-178,088,918.98-233,326,458.32
  减:现金的期初余额-233,326,458.32-221,720,947.36
  现金及现金等价物的净增加额--55,237,539.34-11,605,510.96
公告日期2025-10-292025-08-282025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑